| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.7M | +27.9% |
| R&D Expense | $96.9M | +25.0% |
| SG&A Expense | $39.9M | +45.0% |
| Operating Income | -$127.2M | -30.4% |
| Interest Expense | $0 | — |
| Income Tax | $0 | — |
| Net Income | -$123.3M | -26.8% |
| EPS (Basic) | -$2.94 | -8.5% |
| EPS (Diluted) | -$2.94 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.7M | -34.8% |
| Short-term Investments | $297.5M | +99.8% |
| Accounts Receivable | $2.0M | -0.8% |
| Current Assets | $340.3M | +62.5% |
| Total Assets | $350.6M | +58.5% |
| Current Liabilities | $23.9M | +42.1% |
| Long-term Debt | $9.9M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.6M | -25.4% |
| Capital Expenditures | $1.8M | -9.9% |
| Investing Cash Flow | -$150.2M | -303.8% |
| Financing Cash Flow | $226.9M | +8877.2% |
| Free Cash Flow | -$96.4M | -24.5% |
| -8.5% |
| Total Liabilities |
| $37.3M |
| +68.2% |
| Stockholders' Equity | $313.3M | +57.4% |